Related Experiment Video
Updated: Jan 10, 2026

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
Published on: June 6, 2020
Stakeholders' Experiences and Perspectives of Patient and Public Involvement (PPI) in Maternal and Neonatal Clinical
Kathleen Hannon1,2, Jessica Eustace-Cook3, Déirdre Daly1,4
1School of Nursing and Midwifery, Trinity College Dublin, The University of Dublin, Dublin, Co. Dublin, Ireland.
Introduction:
While there is a growing emphasis on Patient and Public Involvement (PPI) within maternal and neonatal research, there is a lack of evidence on how PPI is currently implemented. The aim of this qualitative evidence synthesis was to gain insight into stakeholders' experiences and perspectives of PPI in maternal and neonatal trials.
Methods:
CINAHL, MEDLINE, PsycINFO, EMBASE, Web of Science, and Maternity and Infant Care (OVID) were searched from inception dates to September 2023, supplemented by a search of Google Scholar. Eligibility screening and quality appraisal of each included record were independently undertaken by two reviewers. Data extracted from the included records were thematically synthesised using Thomas and Harden's approach.
Results:
Nine records were identified as eligible and included in the review. Three themes were generated from the synthesis, each with two or three subthemes. The main themes were 'building a successful PPI partnership', 'impact of PPI on trial design and development', and 'impact of PPI on stakeholders'. Of 15 discrete findings, 1 was assessed as having high confidence, 11 as moderate and 3 were assessed as having low confidence.
Conclusion:
Researchers who facilitated PPI described it as a positive and enjoyable experience that improved trial design and considered PPI as an asset to research. However, there was a lack of information available on PPI contributors' first-hand perspectives or experiences, which considerably limits our understanding of their opinions on how PPI is currently conducted.
Protocol Registration:
The protocol for this qualitative evidence synthesis was registered on PROSPERO (PROSPERO registration number CRD42023383878).
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Patient-centered Care
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Bioavailability Study Design: Healthy Subjects Versus Patients
Nursing Interventions II: Selecting and Classifying the Nursing Interventions

